{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:09:45Z","timestamp":1789416585307,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MD011764"],"award-info":[{"award-number":["MD011764"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL119952"],"award-info":[{"award-number":["HL119952"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL117191"],"award-info":[{"award-number":["HL117191"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL138098"],"award-info":[{"award-number":["HL138098"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL149693"],"award-info":[{"award-number":["HL149693"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.anai.2020.12.005","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T18:26:19Z","timestamp":1607711179000},"page":"284-291.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Serum insulin-like growth factor-1, asthma, and lung function among British adults"],"prefix":"10.1016","volume":"126","author":[{"given":"Yueh-Ying","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Forno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Celed\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anai.2020.12.005_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1513\/AnnalsATS.201703-259OC","article-title":"The economic burden of asthma in the United States, 2008-2013","volume":"15","author":"Nurmagambetov","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.anai.2020.12.005_bib3","series-title":"The economic burden of lung disease. The European Lung White Book: Respiratory Health and Disease in Europe","first-page":"16","author":"Gibson","year":"2013"},{"issue":"1","key":"10.1016\/j.anai.2020.12.005_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12916-016-0657-8","article-title":"The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases","volume":"14","author":"Mukherjee","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.anai.2020.12.005_bib5","author":"Asthma"},{"issue":"12","key":"10.1016\/j.anai.2020.12.005_bib6","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/thoraxjnl-2019-213350","article-title":"Changes in asthma mortality in England and Wales since 2001","volume":"74","author":"Shaw","year":"2019","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.anai.2020.12.005_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/mp.54.5.311","article-title":"Insulin-like growth factor 1 (IGF-1): a growth hormone","volume":"54","author":"Laron","year":"2001","journal-title":"Mol Pathol"},{"key":"10.1016\/j.anai.2020.12.005_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12967-015-0762-z","article-title":"Insulin-like growth factor-1 deficiency and metabolic syndrome","volume":"14","author":"Aguirre","year":"2016","journal-title":"J\u00a0Transl Med"},{"issue":"2","key":"10.1016\/j.anai.2020.12.005_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/01.RES.86.2.125","article-title":"The insulin-like growth factor axis: a review of atherosclerosis and restenosis","volume":"86","author":"Bayes-Genis","year":"2000","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.anai.2020.12.005_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11523-017-0514-5","article-title":"Insulin-like growth factor (IGF) pathway targeting in cancer: role of the IGF axis and opportunities for future combination studies","volume":"12","author":"Simpson","year":"2017","journal-title":"Target Oncol"},{"key":"10.1016\/j.anai.2020.12.005_bib11","first-page":"6057589","article-title":"Insulin-like growth factor-1 signaling in lung development and inflammatory lung diseases","volume":"2018","author":"Wang","year":"2018","journal-title":"BioMed Res Int"},{"issue":"1-2","key":"10.1016\/j.anai.2020.12.005_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cellimm.2007.09.010","article-title":"Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology","volume":"252","author":"O\u2019Connor","year":"2008","journal-title":"Cell Immunol"},{"issue":"6","key":"10.1016\/j.anai.2020.12.005_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI0215463","article-title":"Circulating levels of IGF-1 directly regulate bone growth and density","volume":"110","author":"Yakar","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.anai.2020.12.005_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1165\/rcmb.2013-0397TR","article-title":"Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma","volume":"50","author":"Lee","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.anai.2020.12.005_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cellimm.2005.07.006","article-title":"Role of insulin-like growth factor-I in allergen-induced airway inflammation and remodeling","volume":"235","author":"Yamashita","year":"2005","journal-title":"Cell Immunol"},{"issue":"7","key":"10.1016\/j.anai.2020.12.005_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1164\/rccm.200810-1555OC","article-title":"Role of insulin-like growth factor binding protein-3 in allergic airway remodeling","volume":"180","author":"Veraldi","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.anai.2020.12.005_bib17","first-page":"691","article-title":"High serum levels of IGF-I and IGFBP3 may increase comorbidity risk for asthmatic patients","volume":"118","author":"Acat","year":"2017","journal-title":"Bratisl Lek Listy"},{"issue":"2","key":"10.1016\/j.anai.2020.12.005_bib18","first-page":"112","article-title":"Role of IGF-I, IGF-II and IGFBP-3 in lung function of males: the Caerphilly Prospective Study","volume":"5","author":"Green","year":"2014","journal-title":"Int J Mol Epidemiol Genet"},{"issue":"7","key":"10.1016\/j.anai.2020.12.005_bib19","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1210\/jc.2008-2662","article-title":"Association between serum insulin-like growth factor (IGF) I and IGF binding protein-3 and lung function","volume":"94","author":"Glaser","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.anai.2020.12.005_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.anai.2020.12.005_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2020.12.005_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ije\/dym276","article-title":"The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine","volume":"37","author":"Elliott","year":"2008","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.anai.2020.12.005_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.anai.2020.12.005_bib26","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"issue":"4","key":"10.1016\/j.anai.2020.12.005_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ppul.22822","article-title":"Serum insulin-like growth factor-1 (IGF-1) during CF pulmonary exacerbation: trends and biomarker correlations","volume":"49","author":"Gifford","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.anai.2020.12.005_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1183\/20734735.000318","article-title":"Sex differences in respiratory function","volume":"14","author":"LoMauro","year":"2018","journal-title":"Breathe (Sheff)"},{"issue":"2","key":"10.1016\/j.anai.2020.12.005_bib29","first-page":"1266","article-title":"Upregulated IGF1 in the lungs of asthmatic mice originates from alveolar macrophages","volume":"19","author":"He","year":"2019","journal-title":"Mol Med Rep"},{"issue":"3","key":"10.1016\/j.anai.2020.12.005_bib30","first-page":"2381","article-title":"Insulinlike growth factor 1 inhibits phagocytosis of alveolar epithelial cells in asthmatic mice","volume":"20","author":"Mu","year":"2019","journal-title":"Mol Med Rep"},{"issue":"7","key":"10.1016\/j.anai.2020.12.005_bib31","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1365-2222.2010.03527.x","article-title":"Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells","volume":"40","author":"Kawaguchi","year":"2010","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2020.12.005_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diacare.28.1.120","article-title":"Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance","volume":"28","author":"Sesti","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.anai.2020.12.005_bib33","doi-asserted-by":"crossref","first-page":"9378","DOI":"10.1038\/s41598-018-26621-z","article-title":"The relationship between metabolic syndrome and asthma in the elderly","volume":"8","author":"Park","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.anai.2020.12.005_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaci.2015.01.010","article-title":"Insulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthma","volume":"136","author":"Forno","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2020.12.005_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/CS20080382","article-title":"IGF-I\/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome","volume":"116","author":"Sierra-Johnson","year":"2009","journal-title":"Clin Sci (Lond)"},{"issue":"9","key":"10.1016\/j.anai.2020.12.005_bib36","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120620312436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120620312436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:23:20Z","timestamp":1778588600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120620312436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1081120620312436"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2020.12.005","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum insulin-like growth factor-1, asthma, and lung function among British adults","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2020.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}